IOVA FY 2021 Earnings — Iovance Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

IOVAIovance Biotherapeutics, Inc.

$2B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$343M

Net Income

-$342M

EPS (Diluted)

$-2.23

Cash Flow

Operating Cash Flow

-$228M

Free Cash Flow

-$266M

Stock-Based Comp.

$70M

Balance Sheet

Total Assets

$777M

Total Liabilities

$156M

Stockholders' Equity

$622M

Cash & Equivalents

$78M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$343M	-$262M	-30.8%
Net Income	-$342M	-$260M	-31.8%